 |
|
Genetic Studies on Chromosome 12 in Late-Onset Alzheimer Disease
William S. Wu, MS;
Peter Holmans, PhD;
Fabienne Wavrant-DeVrièze;
Shantia Shears;
Patrick Kehoe;
Richard Crook;
Jeremy Booth;
Nigel Williams;
Jordi Pérez-Tur, PhD;
Kimberly Roehl;
Iain Fenton;
Marie-Christine Chartier-Harlin, PhD;
Simon Lovestone, MD;
Julie Williams, PhD;
Mike Hutton, PhD;
John Hardy, PhD;
Michael J. Owen, MD;
Alison Goate, PhD
JAMA. 1998;280:619-622.
Context.— The only genetic locus universally accepted to be important as a risk factor for late-onset Alzheimer disease (AD) is the apolipoprotein E (APOE) locus on chromosome 19. However, this locus does not account for all the risk in late-onset disease, and a recent report has suggested a second locus on chromosome 12p11-12.
Objective.— To look for evidence of linkage on chromosome 12 and to test for the presence of the new locus in an independent sample of familial late-onset AD cases.
Design.— Retrospective cohort study. As part of a 20-centimorgan genome screen (approximately equal to 200 markers), we tested a series of 18 genetic markers on chromosome 12 and carried out multipoint, nonparametric lod score and exclusion analyses.
Setting.— Clinic populations in the continental United States selected from the National Institute of Mental Health AD Genetics Consortium.
Patients.— We selected samples for DNA analysis from affected sibling pairs, 497 subjects from 230 families with 2 or more affected individuals with probable or definite AD with onset ages older than 60 years (mean±SD, 75±6 years). Within the families, we used the 2 probable or definitely affected individuals. In families with more than 2 such cases available, we used all of them; in families with only 2 such cases in which unaffected individuals were available, we also sampled the oldest unaffected individual and used genotype data from this unaffected individual to check for nonpaternity and genotyping errors.
Main Outcome Measure.— Presence of linkage or locus on chromosome 12.
Results.— Although linkage analyses confirmed the presence of a genetic susceptibility factor at the APOE locus in these families with late-onset AD, we were unable to confirm the presence of a locus close to the marker D12S1042. A moderate lod score (1.91) was found near D12S98 close to the  2-macroglobulin locus in the affected pairs in which both members did not possess an APOE  4 allele.
Conclusions.— APOE remains the only locus established to be a risk factor for late-onset AD. We were unable to confirm that a locus on chromosome 12p11-12 has a major effect on risk for late-onset AD, although an effect smaller than that for APOE cannot be excluded.
From the Departments of Psychiatry and Genetics, Washington University School of Medicine, St Louis, Mo (Messrs Wu and Booth, Mss Shears and Roehl, and Dr Goate); Neuropsychiatric Genetics Unit, University of Wales College of Medicine, Cardiff (Drs Holmans, Owen, and Williams and Messrs Kehoe, Williams, and Fenton); Mayo Clinic Jacksonville, Jacksonville, Fla (Ms Wavrant-DeVrièze, Mr Crook, and Drs Pérez-Tur, Hutton, and Hardy); INSERM, Institut Pasteur de Lille, Lille, France (Ms Wavrant-DeVrièze and Dr Chartier-Harlin); and Section of Old Age Psychiatry, Institute of Psychiatry, London, England (Dr Lovestone).
RELATED LETTER
Further Evidence Linking Late-Onset Alzheimer Disease With Chromosome 12
William K. Scott, Janet M. Grubber, Suzanne M. Abou-Donia, Tony D. Church, Ann M. Saunders, Allen D. Roses, Margaret A. Pericak-Vance, P. Michael Conneally, Gary W. Small, and Jonathan L. Haines
JAMA. 1999;281(6):513-514.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Evidence for an Alzheimer Disease Susceptibility Locus on Chromosome 12 and for Further Locus Heterogeneity
Ekaterina Rogaeva, Smita Premkumar, Youqiang Song, Sandro Sorbi, Nicholas Brindle, Andrew Paterson, Ranjan Duara, Georges Levesque, Gang Yu, Masaki Nishimura, Masaki Ikeda, Colleen O'Toole, Toshitaka Kawarai, Ricardo Jorge, Daniel Vilarino, Amalia C. Bruni, Lindsay A. Farrer, and Peter H. St. George-Hyslop
JAMA. 1998;280(7):614-618.
ABSTRACT
| FULL TEXT
Untangling the Genetics of a Complex Disease
Mark J. Daly
JAMA. 1998;280(7):652-653.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Common genetic variation within the Low-Density Lipoprotein Receptor-Related Protein 6 and late-onset Alzheimer's disease
De Ferrari et al.
Proc. Natl. Acad. Sci. USA 2007;104:9434-9439.
ABSTRACT
| FULL TEXT
The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between {beta}-amyloid production and tau phosphorylation in Alzheimer disease
Kimura et al.
Hum Mol Genet 2007;16:15-23.
ABSTRACT
| FULL TEXT
Expanded Genomewide Scan Implicates a Novel Locus at 3q28 Among Caribbean Hispanics With Familial Alzheimer Disease
Lee et al.
Arch Neurol 2006;63:1591-1598.
ABSTRACT
| FULL TEXT
Further evidence for LBP-1c/CP2/LSF association in Alzheimer's disease families
Bertram et al.
J. Med. Genet. 2005;42:857-862.
ABSTRACT
| FULL TEXT
Polymorphisms in the Oxidized Low-Density Lipoprotein Receptor-1 Gene and Risk of Alzheimer's Disease
D'Introno et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2005;60:280-284.
ABSTRACT
| FULL TEXT
Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family
Li et al.
Proc. Natl. Acad. Sci. USA 2004;101:15688-15693.
ABSTRACT
| FULL TEXT
Familial clustering and genetic risk for dementia in a genetically isolated Dutch population
Sleegers et al.
Brain 2004;127:1641-1649.
ABSTRACT
| FULL TEXT
Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin
Saunders et al.
Hum Mol Genet 2003;12:2765-2776.
ABSTRACT
| FULL TEXT
Review: The renin-angiotensin-aldosterone system and Alzheimer's disease?
Kehoe
Journal of Renin-Angiotensin-Aldosterone System 2003;4:80-93.
ABSTRACT
Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease
Lambert et al.
J. Med. Genet. 2003;40:424-430.
ABSTRACT
| FULL TEXT
Genotype and phenotype in Alzheimer's disease
HOLMES
Br. J. Psychiatry 2002;180:131-134.
ABSTRACT
| FULL TEXT
Familial Alzheimer Disease Among Caribbean Hispanics: A Reexamination of Its Association With APOE
Romas et al.
Arch Neurol 2002;59:87-91.
ABSTRACT
| FULL TEXT
Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland
Hiltunen et al.
Neurology 2001;57:1663-1668.
ABSTRACT
| FULL TEXT
Genome-Wide Linkage Analysis Reveals Evidence of Multiple Regions That Influence Variation in Plasma Lipid and Apolipoprotein Levels Associated With Risk of Coronary Heart Disease
Klos et al.
Arterioscler. Thromb. Vasc. Bio. 2001;21:971-978.
ABSTRACT
| FULL TEXT
Dementia, Quantitative Neuroimaging, and Apolipoprotein E Genotype
Bigler et al.
Am. J. Neuroradiol. 2000;21:1857-1868.
ABSTRACT
| FULL TEXT
The {{alpha}}2-macroglobulin gene in AD: A population-based study and meta-analysis
Koster et al.
Neurology 2000;55:678-684.
ABSTRACT
| FULL TEXT
The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease
Lambert et al.
Hum Mol Genet 2000;9:2275-2280.
ABSTRACT
| FULL TEXT
The molecular and genetic basis of AD: The end of the beginning: The 2000 Wartenberg lecture
Rosenberg
Neurology 2000;54:2045-2054.
FULL TEXT
Verifying the Stroke-Free Phenotype by Structured Telephone Interview
Meschia et al.
Stroke 2000;31:1076-1080.
ABSTRACT
| FULL TEXT
Further Evidence Linking Late-Onset Alzheimer Disease With Chromosome 12
Scott et al.
JAMA 1999;281:513-514.
FULL TEXT
Untangling the Genetics of a Complex Disease
Daly
JAMA 1998;280:652-653.
FULL TEXT
|
